News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,916 Results
Type
Article (1921)
Company Profile (2)
Press Release (67993)
Section
Business (21543)
Career Advice (9)
Deals (4571)
Drug Development (8161)
FDA (1811)
Job Trends (800)
News (37120)
Policy (3565)
Tag
Academia (92)
Allergies (3)
Alliances (8135)
ALS (4)
Alzheimer's disease (122)
Antibody-drug conjugate (ADC) (11)
Approvals (1837)
Artificial intelligence (13)
Automation (1)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (19)
Biotechnology (5)
Bladder cancer (6)
Brain cancer (1)
Breast cancer (17)
Cancer (185)
Cardiovascular disease (5)
Career advice (9)
CAR-T (2)
Cell therapy (21)
Clinical research (6990)
Collaboration (87)
Compensation (10)
Complete response letters (2)
COVID-19 (184)
C-suite (13)
Cystic fibrosis (4)
Data (165)
Depression (1)
Diabetes (13)
Diagnostics (596)
Digital health (1)
Drug discovery (12)
Duchenne muscular dystrophy (12)
Earnings (7647)
Events (6980)
Executive appointments (47)
FDA (1939)
Featured Employer (1)
Fibrodysplasia Ossificans Progressiva (1)
Funding (52)
Gene editing (3)
Gene therapy (16)
GLP-1 (43)
Government (233)
Guidances (4)
Healthcare (1136)
IgA nephropathy (3)
Immunology and inflammation (1)
Indications (3)
Infectious disease (190)
Inflammatory bowel disease (17)
Influenza (5)
Intellectual property (16)
IPO (1642)
Job creations (240)
Job search strategy (9)
Layoffs (6)
Legal (949)
Liver cancer (16)
Lung cancer (30)
Lymphoma (10)
Manufacturing (28)
MASH (6)
Medical device (1121)
Medtech (1122)
Mergers & acquisitions (3015)
Metabolic disorders (37)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (6)
Neuroscience (158)
NextGen: Class of 2025 (219)
Non-profit (61)
Northern California (122)
Obesity (16)
Opinion (1)
Ovarian cancer (10)
Pain (4)
Pancreatic cancer (7)
Parkinson's disease (12)
Partnered (2)
Patents (16)
Patient recruitment (6)
People (4984)
Pharmaceutical (3)
Phase I (1900)
Phase II (2924)
Phase III (2655)
Pipeline (98)
Postmarket research (241)
Preclinical (663)
Press Release (2)
Prostate cancer (5)
Radiopharmaceuticals (22)
Rare diseases (24)
Real estate (599)
Regulatory (2588)
Reports (6)
Research institute (91)
Schizophrenia (6)
Series A (13)
Series B (4)
Service/supplier (1)
Sickle cell disease (1)
Southern California (142)
Spinal muscular atrophy (4)
Startups (421)
Supply chain (6)
United States (1198)
Vaccines (21)
Venture capitalists (2)
Webinars (1)
Weight loss (2)
Women's health (1)
Date
Today (3)
Last 7 days (63)
Last 30 days (245)
Last 365 days (3060)
2025 (632)
2024 (3269)
2023 (3827)
2022 (7022)
2021 (6394)
2020 (5892)
2019 (3869)
2018 (3010)
2017 (3581)
2016 (3191)
2015 (4047)
2014 (3032)
2013 (2627)
2012 (2784)
2011 (2909)
2010 (2664)
Location
Africa (79)
Alabama (1)
Arizona (8)
Asia (21443)
Australia (2429)
California (308)
Canada (211)
China (142)
Colorado (4)
Connecticut (13)
Delaware (4)
Europe (12412)
Florida (35)
Georgia (7)
Illinois (16)
India (10)
Indiana (2)
Japan (68)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (74)
Massachusetts (215)
Michigan (2)
Minnesota (26)
Missouri (3)
Nebraska (1)
Nevada (1)
New Jersey (175)
New York (133)
North Carolina (55)
Northern California (122)
Ohio (3)
Oregon (1)
Pennsylvania (50)
South America (106)
Southern California (142)
Tennessee (1)
Texas (25)
Utah (12)
Virginia (22)
Washington D.C. (2)
Washington State (11)
Wisconsin (6)
69,916 Results for "inspiremd ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results
March 12, 2025
·
13 min read
Press Releases
InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results
February 26, 2025
·
1 min read
Press Releases
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 21, 2025
·
5 min read
Press Releases
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 4, 2025
February 5, 2025
·
5 min read
Press Releases
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures
February 13, 2025
·
7 min read
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, announced the completion of the full exercise of 12.9 million Series H warrants.
July 1, 2024
·
6 min read
Press Releases
InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025
December 12, 2024
·
5 min read
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
InspireMD, Inc. today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
April 3, 2024
·
1 min read
Press Releases
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors
November 26, 2024
·
6 min read
Business
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th
InspireMD, Inc., developer of the CGuard™ Embolic Prevention Stent System device for the treatment of Carotid Artery Disease and stroke prevention, announced it will report first quarter 2024 financial results on Tuesday, May 14th, before the financial markets open.
May 7, 2024
·
3 min read
1 of 6,992
Next
